Enhancing the peripheral chemoreflex to protect the newborn against hypoxic injury – A translational study based on fetal sheep model of birth asphyxia

Bidragets beskrivning

Severe birth asphyxia is a major cause of newborn mortality and in survivors birth asphyxia can cause life-long consequences that can manifest as neurologic morbidities. Birth asphyxia implies a decrease in systemic oxygenation and accumulation of pCO2 in fetal circulation. Typically during labor birth asphyxia develops if reperfusion time between uterine contractions is inadequate or placental function is suboptimal. If the newborn suffers from birth asphyxia, therapeutic hypothermia is the treatment of choice. In this study, we propose a new treatment to minimize the asphyxia-related brain abnormalities and improve long-term neurologic outcome. We test whether acetazolamide medication when given to the asphyxiated newborn will improve outcome. Studies on rats and mice have shown that acetazolamide significantly improves tissue oxygenation and inhibits seizure activity. We use fetal sheep model to test, if this drug can prevent newborn short- and long-term neurologic problems.
Visa mer

Startår

2021

Slutår

2023

Beviljade finansiering

Juha Räsänen
250 000 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiprojekt

Övriga uppgifter

Finansieringsbeslutets nummer

342826

Vetenskapsområden

Genetik, utvecklingsbiologi, fysiologi

Forskningsområden

Kehitysbiologia ja fysiologia

Identifierade teman

gynecology, pediatrics